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Abstract
Background: The re-replication inhibitor Geminin binds to several transcription factors including
homeodomain proteins, and to members of the polycomb and the SWI/SNF complexes.
Results:  Here we describe the TATA-binding protein-like factor-interacting protein (TIPT)
isoform 2, as a strong binding partner of Geminin. TIPT2 is widely expressed in mouse embryonic
and adult tissues, residing both in cyto- and nucleoplasma, and enriched in the nucleolus. Like
Geminin, also TIPT2 interacts with several polycomb factors, with the general transcription factor
TBP (TATA box binding protein), and with the related protein TBPL1 (TRF2). TIPT2 synergizes
with geminin and TBP in the activation of TATA box-containing promoters, and with TBPL1 and
geminin in the activation of the TATA-less NF1 promoter. Geminin and TIPT2 were detected in
the chromatin near TBP/TBPL1 binding sites.
Conclusion: Together, our study introduces a novel transcriptional regulator and its function in
cooperation with chromatin associated factors and the basal transcription machinery.
Background
The core promoter is defined as the genomic region
required for recruitment of the transcription apparatus
and can be considered as the priming stage for transcrip-
tion initiation [1]. Recruitment of RNA polymerase II
requires the assembly of a preinitiation complex, includ-
ing the basal transcription factors TFIIA, B, D, E, F and H
near the transcriptional start site(s) [2]. In addition, tran-
scriptional regulation often involves TAFs (TATA-associ-
ated factors), mediator complex(es), and positive or
negative cofactors, which associate with cis-acting DNA
sequences often located further upstream or sometimes
downstream of the start site [1]. Only 10–20% of the pro-
moters in mammals, Drosophila and Arabidopsis contain
a TATA box, a conserved AT-rich sequence motif approxi-
mately 30 bp upstream from the first transcribed nucle-
otide [3-8]. In mammals, this minority of promoters is
often associated with tissue-specific genes and high con-
servation across species [9,10]. The TATA box associates
with TBP, the TATA box binding protein, which as an ele-
ment of the TFIID factor also binds to many TATA-less
promoters [11-14]. Genomic screening approaches in
yeast suggest that the presence of TBP in the chromatin
near a promoter does not necessarily correspond to tran-
scriptional activity [15-17]. The adenovirus major late
promoter (AdMLP) is a classical example for a TATA box
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promoter. It contains immediately upstream and down-
stream of the box additional protein binding sequences,
the G-rich TFIIB recognition elements (BREs), which were
also found in TATA-less promoters [18-21].
A TBP-like factor, TBPL1 (TLP/TLF/TRF2) has no affinity
to the TATA box, but binds to other promoter elements,
probably with a TBP-like function [22]. It was found in
association with several promoters, e.g. of the PCNA, the
wee1, the neurofibromytosis type 1 (NF1), the histone H1,
and several ribosomal protein genes [23-30]. However, no
common binding motif could so far be delineated in
mammals or Drosophila.
Geminin is a cell cycle regulatory protein, which functions
through an interaction with the replication licensing fac-
tor Cdt1 [31-33]. In addition, it was identified as a bind-
ing partner of developmental control proteins. It represses
Hox functions during embryogenesis by direct association
with Polycomb members on Hox regulatory chromatin
elements, and by impairing Hox protein action on target
genes through direct binding to the homeodomain
[34,35]. In a similar way, geminin directly interacts and
antagonizes the role of another homeobox protein, Six3
[36]. It represses the activator function of pro-neural basic
helix-loop-helix transcription factors neurogenin 2 and
NeuroD on their target neuron-specific genes by seques-
tering Brg1, the catalytic subunit of the chromatin remod-
eling complex SWI/SNF [37]. Alternatively, geminin
represses neuronal gene transcription in non-neural cells
through its association with the AP4 transcription factor,
by recruiting the co-repressor SMRT and histone deacety-
lase HDAC3 to neuronal gene promoters [38].
Here, we describe the function of TIPT2, a protein we
identified through its interaction with geminin. Both
geminin and TIPT2 bind to the basic transcriptional
machinery, and can activate transcription synergistically.
They were found, alone or together, associated with the
chromatin of specific promoters.
Results
We previously identified the polycomb factor Scmh1 and
the homeodomain proteins Hoxd10 and Hoxa11 as gem-
inin binding partners in a yeast two-hybrid screen of a day
8.5 mouse embryo cDNA library [34]. In the same screen,
a strongly interacting protein was identified, encoded by a
715 bp, poly(A)-tailed cDNA, corresponding to the Riken
cDNA clone 5133400G04 [GenBank:NM_029485]. A
database entry identified the protein as isoform 2 of
"TIPT" (TATA-binding protein-like factor-interacting pro-
tein), more recently named TRF2 interacting protein in
testis [GenBank:AAV97890] [39]. TIPT is encoded by
three differentially spliced variants, TIPT isoform 1 [Gen-
Bank:AAV97890] (185 amino acids), TIPT isoform 2
[GenBank:AAH60950] (205 amino acids) and TIPT iso-
form 3 [GenBank:BAB30197](159 amino acids). Mam-
malian TIPTs are strongly conserved, often represented by
several isoforms, but related proteins were not found in
other vertebrates or Drosophila. There are no similarities
to other known proteins, and no conserved domain was
obvious. Two coiled-coil regions (amino acids 50–106
and 128–168), known to be protein-protein interaction
sites, were predicted by the Simple Modular Architecture
Research Tool program http://smart.embl-heidelberg.de/.
TIPT2 expression
RNA from murine tissues was analyzed by Northern blot-
ting. A transcript corresponding in length to isoform 2 of
TIPT was found in all studied tissues (adult heart, brain,
liver, spleen, kidney, lung, thymus, testes, ovary, and day
14 embryo), with particular abundance in testis (Figure
1A). RNA from younger embryonic stages was checked for
the presence of TIPT2 mRNA by RT-PCR. Significant tran-
script levels were detected in day 7.5 and 8.5 embryos, and
even more abundant levels in day 9.5, 10.5, and 11.5
embryos (Figure 1B). A polyclonal antibody was gener-
ated for further descriptive and functional analysis using
for immunization the full-length mouse protein, cleaved
from the purified E.coli recombinant GST-TIPT2 protein
with thrombin, SDS-PAGE gel-purified, and verified by
mass spectroscopy (Figure 1B). Immuno-purified anti-
bodies detected the affinity-purified tagged and untagged
bacterially expressed proteins (Figure 1C), and also the
endogenous TIPT2 from HeLa or U2OS whole cell extract
(Figure 1D). The detection of TIPT2 on Western blots
could be blocked by GST-TIPT2 (Figure 1D). The major
protein band detected by anti-TIPT2 antibodies in unfrac-
tionated extracts from HeLa, U2OS and other cells, and in
organ extracts from newborn mice migrated slightly
slower than the calculated size of 23,500 Da (Figure 1D,
E, data not shown). The anti-TIPT2 antibody detected a
larger sized protein band on some Western blots of gel
purified TIPT2, and of protein extracts generated from
mouse organs (Figure 1E, data not shown). After transfec-
tion of plasmids encoding tagged versions of TIPT2 the
same bands were detected by anti-TIPT2 or anti-Tag anti-
bodies (data not shown). After immunoprecipitation of
HA-TIPT2 with HA antibodies the same pattern was
detected by either anti-HA or anti-TIPT2 antibodies, and
mass spectroscopy indicated HA-TIPT2 as the major pre-
cipitated protein (data not shown).
In mouse embryonic stem cells, SNL and NIH 3T3 mouse
fibroblasts, monkey Cos-7, RD rat rabdomyosarcoma,
HeLa human cervical cancer, and U2OS human osteosar-
coma cells TIPT2 was localized both in cytoplasm and
nucleus, with particular enrichment in nucleoli (Figure
1F, Additional file 1, data not shown). There, it co-local-
ized with nucleolar markers, such as the basal transcrip-BMC Biochemistry 2009, 10:16 http://www.biomedcentral.com/1471-2091/10/16
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tion factor TBPL1, nucleophosmin (NPM), and the 15.5 K
protein (Snu13p in yeast) [40-42]. HA-tagged TIPT2 co-
localized in nucleoli and nucleoplasma with GFP-TBP
after co-transfection of expression vectors (Additional file
1).
TIPT2 interacting proteins
The identification of TIPT2 in a yeast two-hybrid screen
using geminin as bait prompted the investigation of an
interaction with several candidates found in the chroma-
tin or near promoters. In vitro pull-down assays were used
RNA and protein expression of TIPT2 Figure 1
RNA and protein expression of TIPT2. (A) TIPT2 transcripts in mouse adult organs and embryonic (E14) tissues detected 
by Northern blotting. Beta actin was used as a loading control. (B) TIPT2 transcript in embryonic tissues prepared at the indi-
cated stages of development detected by RT-PCR. a, m, and p RNAs were prepared from anterior, middle and posterior 
embryonic regions, respectively. (C) Bacterially made TIPT2 proteins. Lane 1: Marker. Lane 2: Coomassie blue stained recom-
binant GST-TIPT2. Lane 3: TIPT2, generated by thrombin cleavage, removal of GST by glutathione chromatography, and 
thrombin removal by benzamidine chromatography. Lane 4: Material equivalent to the protein in lane 3 was cut from a gel and 
electrophoresed again. (D) TIPT2 proteins detected by purified anti-TIPT antibodies in HeLa or U2OS whole cell extracts (lane 
2 and 3). Detection of TIPT2 on the Western blot was competed by the inclusion of GST-TIPT2 in the antibody binding solu-
tion in a 10:1 ratio (lane 4). Markers were run on lanes 1 and 5. (E) TIPT2 proteins in organ extracts from P2 mice, adult mouse 
testis and a stable U2OS cell line expressing FHM-TIPT2. Asterisks indicate additional proteins recognized by anti-TIPT2 anti-
bodies. (F) Cytoplasmic, nucleoplasmic and nucleolar localization of TIPT2 in human U2OS tissue culture cells. Nucleoli were 
detected with anti-TBPL1 antibodies. DNA was stained with DAPI. Bar, 20 μm. Further immunohistochemistry is presented in 
Additional file 1.BMC Biochemistry 2009, 10:16 http://www.biomedcentral.com/1471-2091/10/16
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to ensure that TIPT2 interacts directly with geminin (Fig-
ure 2B). To better characterize this interaction, the gemi-
nin binding site for TIPT2 was delineated by peptide array
mapping. Binding of His-geminin to TIPT2 peptides
revealed a basic amino acid rich region, close to the C-ter-
minus of protein (KRKK, amino acids 185–189; Figure
2A). Indeed, a mutated GST-TIPT2 protein (TIPT2m;
KRKK to DRDK) did not bind in vitro translated geminin
(Figure 2B). Since geminin interacts with polycomb pro-
teins, we checked also TIPT2 for a potential interaction. In
vitro pull-down assays indicated the binding of Scmh1,
Mph2, and Ring1B, but not of Mel18 (Figure 2C). In addi-
tion, the interaction of TIPT2 with itself was demonstrated
in vitro. The nucleolar localization of TIPT2 and TBPL1,
and the above mentioned database entry prompted us to
analyze a possible interaction of TIPT2 with factors of the
basal transcription machinery. In vitro, TIPT2 interacted
directly with both TBP and TBPL1, and with TFIIB (Figure
2C). Because geminin binds TIPT2 and the latter binds
basal transcription factors, geminin's interaction with TBP
and TBPL1 was explored. The pull-down assay showed
binding to both TBP family members, but not to TFIIB
(Figure 2D). Further assays were performed in order to
demonstrate the interaction of bacterially synthesized
GST fusion proteins with endogenous proteins of cell
lysates. Ponceau staining indicated equal inputs of GST
proteins (Figure 2E). From an adult testis extract, both
TBP and Geminin could be pulled-down with GST-TIPT2
(Figure 2F), and endogenous TBP could also be bound by
GST-Geminin. However, endogenous TIPT2 could not be
pulled-down by GST-Geminin, possibly because of an
inhibitory effect of the GST tag. TBP in cell lysates pre-
pared from human U2OS cells was pulled-down by both
GST-TIPT2 and GST-Geminin (Figure 2G). In order to
study the in vivo interaction of TIPT2 and TBP transfected
cells were analyzed by co-immunoprecipitation. Anti-HA
antibodies precipitated HA-TIPT2 together with endog-
enous TBP from a stable, HA-TIPT2 expressing cell line
(HA-TIPT8; Figure 2H). In summary, we provide evidence
that both TIPT2 and geminin bind members of the poly-
comb complex as well as basal transcription factors.
TIPT2 and TBP bind to separate DNA elements
Next, we analyzed whether TIPT2 interacts with promoter
sequences. In a gel shift assay, TIPT2 bound strongly to the
TATA box-containing AdMLP (Figure 3A, lanes 2,3). The
interaction was highly specific and could be competed by
cold AdMLP oligonucleotides, but not by high amounts of
non-specific competitors (Figure 3A). Multiple bands
were detected in the gel shift assay, suggesting that TIPT2
may not only interact with DNA as a monomer, but in
addition more than one TIPT2 monomer or a multimer
may bind to the AdMLP oligonucleotide. The migration of
TBP or GST-TIPT2 bound proteins to AdMLP was retarded
when anti-TBP, respectively anti-GST monoclonal anti-
bodies were added to the binding reactions (Figure 3B,
lanes 3,5). An AdMLP oligonucleotide with a mutated
TATA box (AdMLPm1; Figure 3E) was still recognized by
TIPT2, but not by human TBP (Figure 3C, lanes 3,4).
TIPT2 did not bind to an oligonucleotide representing the
AdE4 promoter (Figure 3E) [43], to which TBP bound
strongly (Figure 3C, lanes 5,6). These data indicate that
TIPT2 does not interact with TATA box sequences, and
TBP requires a bona fide TATA box. The AdMLP contains
G-rich BRE elements flanking the TATA box [18,21]. To
reveal the location of the TIPT2 binding site, sequential
mutations were introduced into the BRE elements of
AdMLP (Figure 3E). The binding was impaired only for
AdMLPm3, where the central GG sequence of the BRE
upstream (BREu) element was substituted by TT (Figure
3D, lanes 5,6; 3E). In contrary, the mutations AdMLPm2
and m4–m9 still bound directly to TIPT2 (Figure 3D,
lanes 3,4 and 7–18). The binding of TIPT2 to AdMLP was
competed with the cold oligonucleotides AdMLPm2–m9.
Mutants of the BREu element (m2, m3, m4) did not com-
pete for AdMLP binding (Figure 3F, lanes 4–9), whereas
mutations in the TATA box (m5, m6) or in the BREd ele-
ment (m7, m8, m9) competed well for AdMLP binding
(Figure 3F, lanes 10–19). Together, these findings empha-
sized the importance of the BREu element, in particular its
center position, for the binding of TIPT2. In this context
potential interaction partners of TFIIB were explored. In a
pull-down assay we observed that TIPT2, but not geminin
associated with TFIIB (Figure 2C, D).
TBP retarded significantly AdMLP oligonucleotides,
which were clearly separated from TIPT2/AdMLP bands
(Figure 3G, lanes 2,3). The TBP/AdMLP band completely
disappeared when both TBP and TIPT2 were present in the
binding reaction, while the TIPT2/AdMLP complex was
maintained (Figure 3G, lane 4). More retarded oligonu-
cleotides were observed above the TIPT2/AdMLP DNA
complex, which may indicate the formation of a ternary
TIPT2/TBP/DNA complex, but could not be defined in a
clear band. When anti-TBP antibodies were added to this
binding reaction, the TIPT2/DNA complex was still
present, and even more retarded oligonucleotides were
observed (Figure 3G, lane 5), possibly indicating that
TIPT2 and TBP bind independently of each other to the
AdMLP.
TIPT2, TBP and geminin synergize to activate the TATA 
box-containing promoters
We next performed transient luciferase reporter assays
testing the influence of TIPT2, TBP and/or geminin on the
AdML promoter. Vector encoded proteins were present in
amounts similar to endogenous proteins, as demon-
strated by Western blots for transiently transfected GFP-
TIPT2 and FHM-TIPT2 (data not shown). Transfecting in
addition to TBP also TIPT2, TIPT2m (containing aBMC Biochemistry 2009, 10:16 http://www.biomedcentral.com/1471-2091/10/16
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Interaction partners of TIPT2 and geminin (Gmnn) Figure 2
Interaction partners of TIPT2 and geminin (Gmnn). (A) Binding of His-geminin to an array of 63 peptides with 17 
amino acids overlapping 20-mers derived from the TIPT2 sequence. TIPT2 peptides bound specifically to His-geminin as 
detected by anti-geminin antibodies. KRKK amino acids of TIPT2 were mapped as the geminin-binding domain. (B-G) In vitro 
pull-down assays were performed using purified GST-TIPT2, GST-TIPT2m (containing a mutated geminin-binding site), GST-
Gmnn or GST as bait. As preys were used in vitro transcribed/translated proteins (B-D), mouse adult testis (F) and human 
U2OS cell extracts (G). For experimental details please see methods section. (B) GST-TIPT2, GST-TIPT2m or GST interaction 
with radioactively labelled geminin. (C) GST-TIPT2 binding to in vitro translated Scmh1, Mph2, Ring1B, TBPL1, TBP, TFIIB, 
TIPT2 and Mel18. (D) GST-Gmnn interaction with in vitro translated TBP, TBPL1 and TFIIB. (E) Ponceau staining of GST pro-
teins used for the protein lysate pull-down assays. (F) GST-TIPT2 and GST-Gmnn interaction with endogenous TBP, geminin 
and TIPT2 from adult mouse testis extract. (G) GST-TIPT2 and GST-Gmnn interaction with endogenous TBP from U2OS cell 
extract. The star indicates the cross-reactivity of TBP antibodies raised against GST recombinant human TBP with GST-TIPT2. 
(H) Co-immunoprecipitation of endogenous TBP with HA-TIPT2 using anti-HA antibodies. Extracts from untransfected U2OS 
cells, and from a U2OS clone stably producing HA-TIPT2 (HA-TIPT8), respectively, were analyzed.BMC Biochemistry 2009, 10:16 http://www.biomedcentral.com/1471-2091/10/16
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mutated geminin binding site) or geminin enhanced the
activation of the reporter only marginally (2–3 fold; Fig-
ure 4A). In comparison, the co-transfection of geminin
with TIPT2, but not TIPT2m (p-value < 0,001), was much
more effective (11 fold). An optimal activation level (16
fold) was observed in triple transfections, when TBP,
TIPT2 and geminin were introduced together. This effect
was attenuated when TIPT2m instead of TIPT2 (p-value <
0,001), or TBPL1 instead of TBP (p-value < 0,001) were
applied in triple transfections (Figure 4A). Replacing
Geminin by a mutant lacking the coiled-coil domain
(Gmnn m2) did not change the synergistic effect in triple
transfections, indicating that it did not result from a per-
turbation of the cell cycle or of DNA replication. Transfec-
tion of a Geminin mutant lacking the binding domain for
Brg-1 (Gmnn m3) did not reduce the activity, but resulted
in a slight enhancement (Figure 4B).
Similar transfection experiments were performed compar-
ing the non-mutated AdML promoter with mutants in the
binding sites for either TBP (m1) or TIPT2 (m3). The
background level achieved with single or double transfec-
tions was slightly elevated when TIPT2 and geminin vec-
tors were transfected together (Figure 4C). Here,
differences between the wild-type AdMLP reporter and
reporters with a mutation in either the TIPT2-binding BRE
element, or the TBP-binding TATA box were not recogniz-
able. Double transfections did not produce a significant
difference between the luciferase activities of BREu mutant
or TATA box mutant and wild type AdML promoter (p-
value > 0,01). Maximal luciferase activities were obtained
in triple transfections using the wild-type form. Both the
TATA box and BREu mutated promoters gave lower activa-
tion levels compared to the wild-type promoter (p-value <
0,001, respectively < 0,01; Figure 4C).
To investigate if TIPT2, TBP and geminin also activated a
different TATA-containing promoter, the herpes virus thy-
midine kinase (TK) promoter was assayed, which does not
contain a BRE element upstream of its TATA box. Still, the
transfection results were quite similar to the AdMLP data.
Single transfection of TBP, TIPT2 or geminin, as well as
double transfections of TBP/TIPT2 or TBP/geminin acti-
vated expression only marginally (2–4 fold; Figure 4D).
Triple transfections of TBP, TIPT2, and geminin activated
the reporter very strongly (29 fold) and synergistically.
This effect was TBP-specific, because it could not be
obtained by adding TBPL1 (p-value < 0.01; Figure 4E).
The indicated reporter assays were realized in the presence
of endogenous TIPT2, geminin and TBP, all three proteins
being present in the U2OS cell line. We tried to knock-
down endogenous TIPT2 using various small interfering
(si) RNAs and short hairpin constructs. While TIPT2 RNA
levels could be decreased more than 80%, the protein lev-
els were not significantly affected even after several days
and repeated siRNA transfection (data not shown). How-
ever, endogenous geminin levels could be knocked-down
efficiently with specific siRNA molecules (Figure 4G). The
experiments indicated that both single (TBP; p-value <
0,001) and double overexpressions (TIPT2/TBP; p-value <
0,001) were reduced in the absence of geminin (Figure
4F). Together, these results suggest that TIPT2 synergizes
with geminin and TBP in order to activate TATA-contain-
ing promoters, both in the presence or absence of a TIPT2
binding DNA sequence element. We see significant, logic
changes in the activation of TATA promoters in response
to different protein combinations. It is however apparent,
that we did not necessarily observe a complete abroga-
tion, if one factor was missing, mutated, or its binding site
was removed.
Association of TIPT2 and TBPL1-TFIIA with the 
neurofibromin promoter
Recently, the binding of TBPL1 to a 103 bp fragment of
the NF1 promoter was demonstrated in vitro and in vivo
[26]. It was shown that TBPL1 binds to this promoter on
two different sites and that TBPL1 shifts DNA in complex
with TFIIA. We purified the TBPL1-TFIIA complex from
cytoplasmic and nuclear extracts of a HeLa cell line stably
overexpressing Flag tagged TBPL1 [44]. The NF1 oligonu-
cleotide was retarded significantly by this protein fraction
(Figure 5A, lane 4), while geminin did not bind to it (Fig-
ure 5A, lane 2), and TIPT2 produced bands, which how-
ever were not completely competed for by cold
oligonucleotides (Figure 5A, lane 3). Incubation of
increasing amounts of TIPT2 with the NF1 oligonucle-
otide in the presence of TBPL1-TFIIA resulted in the
appearance of a novel, slower migrating band, suggesting
the binding of TIPT2 and TBPL1-TFIIA on the same oligo-
nucleotide (Figure 5A, lanes 5,6). An influence of geminin
on the TIPT2/TBPL1-TFIIA/NF1 complex could not be
demonstrated clearly by an electrophoretic mobility shift.
Together, these data indicate that TIPT2 associates with
TBPL1-TFIIA on the TATA-less NF1 promoter.
TIPT2, TBPL1 and geminin synergize to activate the TATA-
less NF1 promoter
We next analyzed whether TIPT2 was able to contribute to
the activation of the NF1 promoter by employing luci-
ferase reporter constructs with the NF1 promoter, contain-
ing multiple TBPL1 binding sites [26]. TBPL1, TIPT2 or
geminin alone were not capable of activating the reporter
significantly (Figure 5B). TIPT2 and geminin together pro-
duced already a significant increase (20 fold), and the
additional inclusion of TBPL1 led to a very strong, syner-
gistic activation (44 fold; Figure 5B). Replacing TBPL1 by
TBP revealed that the triple combination TBP/TIPT2/gem-
inin was not more active than just TIPT2/geminin (p-
value < 0,001), indicating that NF1 activation was TBPL1-BMC Biochemistry 2009, 10:16 http://www.biomedcentral.com/1471-2091/10/16
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Binding of TIPT2 and/or TBP to TATA box-containing promoters Figure 3
Binding of TIPT2 and/or TBP to TATA box-containing promoters. (A) Analysis of GST-TIPT2 binding to AdMLP. The 
specificity of the DNA-binding activity of 30 ng GST-TIPT2 was verified by competition with cold poly(dG-dC), poly(dI-dC), 
and unlabeled (*) AdMLP oligonucleotides, respectively. (B) The specificity of TBP and TIPT2 binding to AdMLP was tested by 
antibodies competition. Lane 2: The binding of 6 ng TBP to AdMLP. Lane 3: TBP-AdMLP complex was competed by anti-TBP 
antibodies. Lane 4: The binding of 15 ng GST-TIPT2 to AdMLP oligonucleotides. Lane 5: TIPT2-AdMLP complex was competed 
by anti-GST antibodies. (C) The binding of human TBP (6 ng) or GST-TIPT2 (30 ng) to AdMLP (containing BRE elements and a 
TATA box), AdMLPm1 (TATA box mutated) and AdE4 (no BRE elements). For sequences see Figure 3E. (D) GST-TIPT2 bind-
ing to AdMLP and m2–m9 mutants. (E) Oligonucleotide sequences of AdMLP representing AdMLP (BRE elements in bold), nine 
mutations of AdMLP (mutated bases highlighted), and AdE4. The TATA box motifs are framed. (F) Competition of the interac-
tion between AdMLP and TIPT2 by mutated versions of AdMLP. Unlabelled oligonucleotides were preincubated with 6 ng 
GST-TIPT2. For sequences see Figure 3E. (G) Simultaneous binding of TIPT2 (60 ng) and TBP (6 ng) to AdMLP. The data in Fig-
ure 3B, D, F, G, respectively, stem from the same gel and exposure, the assembly is indicated by white lines.BMC Biochemistry 2009, 10:16 http://www.biomedcentral.com/1471-2091/10/16
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specific (Figure 5B). A knock-down of endogenous gemi-
nin decreased the activity of the NF1 reporter in the pres-
ence of exogenous TBPL1 or TIPT2/TBPL1 to levels
significantly below the control background in the absence
of any siRNA transfected, by a factor of about 4 (p-value <
0,01, respectively < 0,001) (Figure 5C). This result sug-
gests that medium levels of activation in the absence of
transfected geminin benefited from the presence of
endogenous geminin. In summary, we show that TIPT2,
TBPL1 and geminin activate the TATA-less NF1 promoter
construct synergistically.
The presence of TIPT2 and/or geminin in specific 
chromatin
The chromatin of TBP or TBPL1 dependent genes, possess-
ing either TATA box or TATA-less promoters, was assayed
by chromatin immunoprecipitation (ChIP) using in vivo
dual-cross-linking [45,46]. For this purpose the stable
U2OS line generated, which produced HA-TIPT2 at levels
similar to the endogenous protein (clone HA-TIPT8; Fig-
ure 6A) was used. The TATA box-containing regions of the
investigated promoters were positive for TBP and
acetylated histone H3 (Figure 6B). On the HSP70 pro-
moter neither TIPT2 nor geminin were found. On the c-
fos promoter geminin, but not TIPT2, was present in the
chromatin. However, on the GAPDH promoter both
TIPT2 and geminin were found. The TATA-less NF1 pro-
moter region that includes two TBPL1 binding sites was
positive for acetylated H3K9K14, geminin and TIPT2. The
PCR band indicating the presence of TBP had the same
intensity as for the other TATA-containing promoters, but
was not enriched in comparison with mouse IgG. Thus, it
had to remain inconclusive, if TBP is present in the chro-
matin of the NF1 promoter. These results indicate that
TIPT2 and geminin are present alone or together, on the
chromatin of some, but not all tested promoters.
Discussion
Recently, information on a second isoform of TIPT (iso-
form 1) was independently reported [39]. These authors
describe expression in male germ cells, interaction with
TBPL1 (TRF2), DNA binding and association with chro-
matin, in line with our findings on isoform 2. However,
they did not detect the widespread expression we saw on
the RNA and protein level for isoform 2, although probe
and antibodies would be expected to crossreact.
In our study, we describe the synergistic function of two
interacting factors, TIPT2 and geminin, in the activation of
transcription. TIPT2 and geminin have in common that
they can interact with polycomb group members (PcGs),
which are known for their function in the maintenance of
gene repression [47-52]. Therefore, it came unexpected
that PcGs were found together with the basal transcrip-
tional machinery on repressed promoters [49,53]. It lead
to the hypothesis that PcG proteins maintain silencing by
inhibiting general transcription factor-mediated activa-
tion of transcription by interfering with the formation of
the preinitiation complex [54]. Our findings suggest that
TIPT2 and geminin could be involved in the transition
from inactive to active transcription via association with
basal transcription as well as Polycomb factors. We found
both geminin and TIPT2 in the chromatin of transcribed
genes. TIPT2 was significantly enriched in nucleoli, a sub-
cellular localization shared by the bHLH transcription fac-
tor Hand1, the basal transcription factor TBPL1, by
Drosophila testis-specific TAF homologs and, albeit as an
exception, by some PcGs [40,55-57]. For the nuclear gem-
inin, on the other hand, a nucleolar localization was not
specifically described. If we observe a cooperation of these
proteins in Pol II-dependent transcription, their func-
tional interactions must occur in the nucleoplasm. Nucle-
oli might represent a site to keep transcription factors
unavailable for gene regulatory functions, a hypothesis
which may also apply to TIPT2. However, we have prelim-
inary evidence that the nucleolar localization of TIPT2
also reflects a role in the activation of ribosomal RNA by
polymerase I. In addition, our unpublished data indicate
that TIPT2 nucleolar localization is regulated by phospho-
rylation.
Sequences flanking the core TATA box can influence the
assembly of complexes, affect the basal level of transcrip-
tion and the response to activators [58-60]. Our results
show that TIPT2 contacts the AdMLP on a BRE site imme-
diately upstream of the TATA box, without a need for
TFIIB or TBP. In band-shift assays TIPT2/AdMLP com-
plexes run in two or more bands (Figure 3A, lanes 2,3; 3D,
lane 2; 3F, lane2). The faster migrating band represents
TIPT2 associated with the BREu site of the oligonucleotide.
The slower band(s) could represent more than one TIPT2
protein per oligonucleotide, with only one monomer
engaged in DNA interactions. The slower migrating com-
plex becomes more prominent than the faster complex
after addition of cold oligonucleotides with BREu muta-
tions (m2, m3, m4; Figure 3F). This might be indicative of
a second DNA binding site on the TIPT2 protein interact-
ing with the competitor.
The binding of TIPT2 to the BRE site interfered signifi-
cantly with the binding of TBP to the TATA box. Both pro-
teins on one oligonucleotide providing both binding sites
were not clearly demonstratable. But some material of
lower electrophoretic mobility may indicate the forma-
tion of a triple complex, containing AdMLP, TIPT2 and
TBP. This disappeared upon addition of anti-TBP antibod-
ies. ChIP experiments indicated that TBP and TIPT2 could
be associated in vivo with chromatin in the TATA box con-
taining promoter region of the GAPDH gene. While this
finding does not formally prove the simultaneous pres-BMC Biochemistry 2009, 10:16 http://www.biomedcentral.com/1471-2091/10/16
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ence, it appears very unlikely that the active GAPDH pro-
moter exists in two different configurations, being
occupied with either TBP or TIPT2.
Our data suggest that transcriptional activation by TIPT2
is optimal in the presence of a BREu element (AdMLP), but
occurs also with a mutated (AdMLPm3) BREu element or
in its absence (TK promoter). DNA binding of TIPT2
appears not to be essential, and association just by pro-
tein-protein contact seems to be sufficient. A recent bioin-
formatic study revealed that 24.5% of core promoters
from the EPD (Eukaryotic Promoter Database: http://
www.epd.isb-sib.ch), and 25.5% from the DBTSS (Data-
base of Transcriptional Start Sites; http://dbtss.hgc.jp/
Geminin cooperates with TIPT2 and TBP to activate TATA box-containing promoters Figure 4
Geminin cooperates with TIPT2 and TBP to activate TATA box-containing promoters. (A) Activation of the 
AdMLP by the indicated combinations of TIPT2, TIPT2m, TBP, TBPL1 and geminin. (B) Activation of the AdMLP by TBP, TIPT2, 
and geminin or geminin mutants. Gmnn m2 lacks the coiled-coil domain, Gmnn m3 lacks the Brg1 binding domain. (C) Activa-
tion of the reporters pGL3-AdMLP, pGL3-AdMLPm1 (mutated TATA box), and pGL3-AdMLPm3 (mutated BREuelement) by 
the indicated combinations of TBP, TIPT2, and geminin. For sequence motifs see Figure 3E. (D) Activation of the TK promoter 
by the indicated combinations of TBP, TIPT2, and geminin. (E) Activation of the TK promoter by the indicated combinations of 
TBP, TBPL1, TIPT2, and geminin. (F) Activation of the TK promoter by the indicated combinations of TBP, TIPT2, and geminin, 
in the presence of siRNA against geminin. (G) Knock-down of endogenous geminin protein by transfection of U2OS cells with 
siRNA. The level of Lamin B protein indicates the gel loading of the protein extracts.BMC Biochemistry 2009, 10:16 http://www.biomedcentral.com/1471-2091/10/16
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index.html), respectively contain a BREu [4]. More pre-
cisely, 28,1% of TATA-less promoters and 11.8% of TATA-
containing promoters present a BREu. It is therefore con-
ceivable that TIPT2 plays a role in the activation of tran-
scription from many promoters.
The TIPT2 binding protein, geminin, activated transcrip-
tion in several reporter assays. The simultaneous transfec-
tion of geminin and TIPT2 expression vectors boosted the
activation of TATA-containing promoters. A mutant of
TIPT2 that could not interact with geminin was clearly less
active, again underlining the importance of the geminin/
TIPT2 interaction in transcriptional activation. Our results
concerning AdML promoter mutations analysis extends
the previous findings that disruption of BREu decreased
activated transcription [60]. Our data indicate that a sim-
ilar mechanism for transcriptional activation could hold
true in the case of the TATA-less NF1 promoter [61,62].
Mammalian TBPL1 does not stimulate transcription in
vitro from TATA box-containing E4, AdML and Hsp70 pro-
moters [24,44,63,64]. We showed here that TIPT2, TBPL1
and NF1 promoter form a complex in vitro. The synergistic
transcriptional activation of the NF1 promoter by TBPL1,
TIPT2 and geminin is similar to the synergistic activation
we observed for the TATA box-containing promoters
Binding and activation of the NF1 promoter by TIPT2 and  TBPL1 Figure 5
Binding and activation of the NF1 promoter by 
TIPT2 and TBPL1. (A) TIPT2 (120–240 ng) and TBPL1-
TFIIA (20 ng) binding to the NF1 oligonucleotide. Geminin 
(120 ng) binding to the NF1 oligonucleotides. (B) Activation 
of the NF1 promoter by the indicated combinations of 
TIPT2, TBPL1 and geminin. (C) Activation of the NF1 pro-
moter by the indicated combinations of TIPT2, TBPL1 and 
geminin in the presence of siRNA against geminin.
Geminin and TIPT2 in the chromatin of TATA box-contain- ing and TATA-less promoter regions Figure 6
Geminin and TIPT2 in the chromatin of TATA box-
containing and TATA-less promoter regions. ChIP 
assays were performed for promoter regions and the inter-
genic region as indicated, using the U2OS cell line stably pro-
ducing HA-TIPT2 (HA-TIPT8). (A) Western blot analysis of 
HA-TIPT2 protein from different stably transfected clones in 
comparison with endogenous TIPT2 and Lamin B. (B) ChIP 
assay. The acetylated H3 was used as positive control. The 
chromatin was immunoprecipitated with normal mouse IgG 
(IgGm) as negative control for anti-TBP, or with normal rab-
bit IgG (IgGr) for anti-acetylated H3, anti-HA, and anti-gemi-
nin, respectively.BMC Biochemistry 2009, 10:16 http://www.biomedcentral.com/1471-2091/10/16
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(AdML, TK) by TBP, TIPT2 and geminin. It may, however,
be too simplistic to correlate exclusively the TATA box
promoters with TBP, and the TATA-less promoters with
TBPL1 [29].
Down-regulation of geminin levels in human U2OS cells
decreased the activity obtained from activated TK and NF1
promoters, indicating that already the endogenous gemi-
nin plays a significant role in our transcriptional assays.
Geminin was reported to be involved in different, tran-
scription-related complexes as a negative regulator of tran-
scription, either directly or indirectly. In this study we
show geminin's function as transcriptional co-activator.
Other studies have shown that another chromatin remod-
eler, the SWI/SNF complex, is able to act in a gene-
dependent manner either as activator or repressor [65,66].
Our results suggest that geminin may interact with distinct
protein complexes that exhibit cell-type or gene-specific
functions. These interactions may decide if geminin
affects transcription as a transcriptional repressor or acti-
vator.
In agreement with in vitro and reporter assay data, the
chromatin analysis revealed geminin and TIPT2 on TATA-
containing and TATA-less, active gene promoters. On the
active endogenous chromatin, TIPT2 and geminin were
present near the TATA box of the GAPDH gene, but not of
the c-fos or the HSP-70 gene on a distance of two-three
nucleosomes. The active TATA-less NF1 promoter is asso-
ciated with geminin and TIPT2 in the region where TBPL1
was shown to bind. Our own ChIP evidence does not
allow to conclude for the presence of TBP in the chroma-
tin of the NF1 promoter in U2OS cells. However, recently
the presence of TBP was described in the chromatin of the
NF1 promoter in HeLa cells [29].
A genome-wide analysis of TRF2 recognition sites in Dro-
sophila indicates that TRF2, a protein closely related to ver-
tebrate TBPL1, plays a more general role than previously
thought, being required for the expression of more than
1,000 genes, some involved in regulation of chromatin
organization and cell growth (Histone H1 linker and ribos-
omal protein genes) [30]. This may suggest also that in
mammals TBPL1 plays an important role regulating
essential cell functions not only in testis, but also in other
tissues. In this new perspective, our study might indicate
new factors binding to both TBP and TBPL1, which might
constitute co-regulatory proteins common for both core
promoter corresponding complexes.
Conclusion
In conclusion, we suggest that the two interacting proteins
TIPT2 and geminin function as synergistic transcriptional
regulators in contact with both the basal transcriptional




The primers used for this study are listed in Additional file
2. The full-length TIPT2 clone was obtained from the
mouse 8.5 cDNA library used in the yeast-two-hybrid
screen, and included start codon, stop codon and poly A
tail [34].
To construct mouse GST-TIPT2, TIPT2 was amplified from
pPC86-TIPT2, and cloned into pGEX-KT. For the HA-
TIPT2 expression construct, the coding sequence was
inserted into the pcDNA vector (Invitrogen) containing
an intron and a HA epitope (provided by R. Lührmann).
The pFlag-HA-Myc-TIPT2 (FHM-TIPT2) construct was
generated by inserting a TIPT2 PCR product in frame with
the triple tag into the previously described pFHM-IRES-
Neo vector [67]. For in vitro transcription/translation,
SP6/T7 vectors were used or generated with the complete
coding sequences for TIPT2, geminin, Scmh1 [34], Mel18,
Ring1B (provided by H. Koseki), Mph2, TBPL, TBP [68],
and TFIIB [69]. GFP-TBP and GFP-TBPL1 plasmids were
described before, and provided by J.A. Chong [26]. The
pCMV3-geminin construct was previously described [34],
mutant geminin expression vectors lacking the coiled-coil
(Gmnn m2), or the Brg1 binding domain (Gmnn m3),
respectively, were provided by K. Kroll [37]. Reporter plas-
mids were based on pGL3-Basic (Promega), such as pGL3-
TK, pGL3-AdMLP (position -48 to +11; Figure 3E), pGL3-
AdMLPm1 (AdML promoter mutated for TATA box; Fig-
ure 3E), pGL3-AdMLPm3 (AdML promoter mutated for
TIPT2 binding; Figure 3E), and pGL3-AdE4 (position -56
to +39; Figure 3E). To construct the pGL3-NF1 reporter,
first the human NF1 promoter region (position -335 to
+15) [26] was amplified from human genomic DNA, then
cloned into pGL3-Basic, and then, fourfold-reiterated oli-
gonucleotides (position -282 to -259) were ligated into
pGL3-NF1. A plasmid encoding GST-TIPT2 with a muta-
tion in the geminin binding site (GST-TIPT2m) was gen-
erated from GST-TIPT2 plasmid by site directed
mutagenesis. GFP-15.5 K was provided by R. Lührmann.
Protein preparations
Whole cell extract was prepared from HeLa cells using a
modified RIPA buffer (50 mM Tris, pH 7.4, 1% NP-40,
0,25% Na-deoxycholate, 0.5 mM EDTA, 150 mM NaCl, 1
mM PMSF). U2OS whole cell extract was prepared using
lysis buffer (20 mM Tris, pH 7.4, 150 mM NaCl, 1% NP-
40, 1 mM PMSF). Testis extract was prepared from liquid
nitrogen frozen testes of 10 weeks old male mice using tes-
tis lysis buffer (50 mM Tris, pH 8.0, 150 mM NaCl, 0.5%
NP-40, 1 mM PMSF). Organ extracts were prepared fromBMC Biochemistry 2009, 10:16 http://www.biomedcentral.com/1471-2091/10/16
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freshly dissected P2 mice using lysis buffer containing 20
mM Tris, pH 7.5, 150 mM NaCl, 1% NP-40, 1 mM EDTA,
1 mM DTT and protease inhibitor cocktail. TFIIA-TBPL1
complex was purified according to [44], human TBP
according to [70], GST-geminin and His-geminin accord-
ing to [34]. A peptide array (Jerini, Berlin) of overlapping
20-mers derived from the TIPT2 sequence was incubated
with His-geminin and analyzed as described previously
[34].
Recombinant TIPT2 and anti-TIPT2 antibodies
Full-length TIPT isoform 2 and a TIPT2 version mutated in
the geminin binding site were produced as N-terminal
GST fusions by standard procedures. Highly pure protein
preparations were obtained by affinity chromatography
on Glutathione Sepharose. GST-free TIPT2 was generated
by thrombin cleavage on the gel matrix, and thrombin
removal by benzamidine chromatography. TIPT2 was fur-
ther purified from a preparative 15% SDS-PAGE gel, and
its identity was confirmed by mass spectrometry. Gel-
purified TIPT2 protein was used to generate polyclonal
rabbit antibodies (Bioscience, Göttingen). The crude anti-
TIPT2 rabbit serum was purified by chromatography on
matrix coupled GST-TIPT2.
GST pull-down assay
Either radioactive proteins or whole cell extracts were used
as preys. Radioactive binding proteins were generated by
transcription/translation using the TNT SP6/T7 Coupled
Reticulocyte Lysate System (Promega). For the prepara-
tion of the pull-down bait, Glutathione Sepharose-4B
beads (Amersham) were pre-washed in lysis buffer (50
mM Tris pH 7.5, 500 mM NaCl, 2 mM EDTA, 5 mM DTT,
10% glycerol, 1 mM PMSF, Complete-EDTA protease
inhibitors). For coupling, GST-TIPT2, GST-TIPT2m, GST-
geminin, or GST, respectively, were incubated with Glu-
tathione Sepharose-4B beads in binding buffer (20 mM
Tris pH 7.5, 100 mM NaCl, 1 mM EDTA, 0,1% NP-40, 1
mM PMSF, protease inhibitors). GST protein-loaded
beads were washed twice, incubated with radioactively
labelled protein or protein lysates (from U2OS cells or
adult mouse testis) for 1 hour at 4°C in 500 μl of binding
buffer, washed twice in binding buffer, and then twice in
washing buffer containing 150 mM NaCl. Proteins were
eluted in 40 μl SDS loading buffer at 95°C. 20 μl of the
eluted protein were electrophoresed, in parallel to an
input lane containing 20% of the original radioactive pro-
tein preparation, 4% of total U2OS whole cell extract or
10% of testis extract.
Immunoprecipitation
Immunoprecipitations were performed using the anti-HA
affinity matrix (Roche). U2OS and stable, HA-TIPT2 pro-
ducing cells (HA-TIPT8) were used to prepare the protein
extracts and to immunoprecipitate HA-TIPT2 and endog-
enous TBP. The cells were washed with cold PBS, and
lysed with lysis buffer (50 mM Tris-HCl, pH 7.4, 120 mM
NaCl, 1 mM EDTA, 1 mM EGTA, and 1% NP-40, 10 mM
β-glycerol-P, 5 mM K2HPO4) by passage through the nee-
dles and incubating for 1 hour at 4°C. The extracts were
centrifuged, and the supernatants were incubated with
identical amounts of anti-HA agarose beads for several
hours at 4°C. After washing (50 mM Tris HCl, pH 7.4, 150
mM NaCl, 0.1% NP-40), the complexes were eluted by
boiling with 2× sample buffer (125 mM Tris HCl, pH 6.8,
4%SDS, 20% (v/v) glycerol, 0,004% bromphenol blue).
2.5% of the inputs and 50% from the eluates were electro-
phoresed.
Antibodies
The following primary antibodies were used: rabbit anti-
TIPT2, raised against E.coli-expressed gel-purified full-
length TIPT2; rabbit anti-geminin (sc-13015, Santa Cruz);
mouse anti-TBP (3G3; gift from I. Davidson); mouse anti-
TBP (Mab-TBPCSH-100, Diagenode); mouse anti-TBPL1
(2A1, provided by I. Davidson); rabbit anti-HA (ab9110,
Abcam); rat monoclonal anti-HA (clone 3F10, 1867431,
Roche); goat anti-Lamin B (sc-6216, Santa Cruz); mouse
anti-GST (71097–3, Novagen); rabbit anti-acetyl histone
H3 (06–599, Upstate); rabbit IgG (12–370, Upstate);
mouse IgG (12–371, Upstate); mouse anti-NPM (32–
5200, Zymed).
The following secondary antibodies were used: HRP-con-
jugated goat anti-rat IgG (112-035-143, Jackson Immu-
noResearch); HRP-conjugated rabbit anti-goat IgG
(ab6741-1, Abcam); HRP-conjugated goat anti-rabbit IgG
(211–1303, Rockland); HRP-conjugated goat anti-mouse
IgG (115-035-003, Jackson ImmunoResearch); Alexa
Fluor 594 and 488 goat anti-rabbit IgG (A11012, A11008,
Molecular Probes); Alexa Fluor 594 and 488 goat anti-
mouse IgG (A-11005, A-11001, Molecular Probes); Alexa
Fluor 594 chicken anti-rat IgG (A21471, Molecular
Probes).
Electrophoretic mobility shift assays
In vitro interactions of human TBP, human TBPL1 com-
plexed with TFIIA, recombinant GST-TIPT2 and His-gem-
inin proteins with various promoter sequences were
tested. The following, double-stranded oligonucleotides
(see Additional file 2 and Figure 3E for sequences) were
investigated: AdMLP oligonucleotide (position -40 to -16)
[71], AdMLPm1-m9, NF1 oligonucleotide (position -288
to -253) [26,72], AdE4 oligonucleotide [43]. Binding reac-
tions were performed at a final concentration of 5.5 nM
labeled probe, no corrections for cpm were made. Compe-
tition by non-specific oligonucleotides in Figure 3A was
performed at 0.03 μM poly(dI-dC), 0.33 μM poly(dG-BMC Biochemistry 2009, 10:16 http://www.biomedcentral.com/1471-2091/10/16
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dC), 0.08 μM or 0.4 μM double-stranded cold AdMLP. 0.1
μl of mouse anti-TBP (3G3) or mouse anti-GST antibodies
(Novagen) were applied in the last seven minutes of the
binding reactions (Figure 3B, G). For the competition
experiments between AdMLP and TIPT2 by mutated ver-
sions of AdMLP double-stranded, unlabeled oligonucle-
otides were added at a final concentration of 1.6 μM or 5
μM, respectively, in the presence of 6 ng GST-TIPT2 (Fig-
ure 3F). Radiolabeled probe was added 15 min after start-
ing the reaction.
Different binding reactions and electrophoresis condi-
tions were performed for TBP or TBPL1, respectively. TBP
binding reactions were performed in a final volume of 15
μl by mixing 3 μl 5× buffer (60 mM HEPES/KOH, pH 7.6,
300 mM KCl, 15 mM dithiothreitol, 1 mM EDTA, 10%
polyethylene glycol 8000 (w/v), 20 mM MgCl2, 40% glyc-
erol, 0.1% NP-40, 66.65 μg/ml BSA) with poly(dG-dC)
(0.08 μM final concentration), 6 ng TBP, and labeled oli-
gonucleotides (5.5 nM final concentration) [73].
The TBPL1 binding reactions were performed in a final
volume of 15 μl by mixing 5 μl 3× buffer (60 mM HEPES/
KOH, pH 7.6, 180 mM KCl, 9 mM dithiothreitol, 60%
glycerol, 60 μg/ml BSA) with 200 ng BSA, poly(dG-dC)
(0.03 μM final concentration), and 20 ng TBPL1-TFIIA
complex [26]. For checking the binding of both TBP and
TIPT2 to AdMLP oligonucleotides, the proteins were
added simultaneously to the binding reactions. The reac-
tions were incubated at 30°C for 45 minutes. For the elec-
trophoresis 4% polyacrylamide mini-gels (59:1
mono:bisacrylamide ratio, 5% glycerol, 1 mM DTT) were
polymerized for minimum 1 hour and prerun for 45 min-
utes at 200 V and 4°C. For TBP bandshifts the gel was elec-
trophoresed in 0.5× Tris-borate-EDTA (TBE) buffer
supplemented with 5% glycerol [74] and 0.02% NP-40
for 20 minutes at 200 V at 4°C. The TBPL1 gel shift was
electrophoresed in 0.5× TBE buffer for 16 minutes at 400
V and 4°C.
Cell culture and ChIP assay
For the stable production of tagged TIPT2 version, U2OS
cells were transfected with HA-TIPT2 or FHM-TIPT2
expression constructs containing a Neomycin gene cas-
sette. Clones were selected with 500 μg/ml neomycin
(G418), and analyzed for HA-TIPT2 or FHM-TIPT2
expression.
1.5 × 107 HA-TIPT2 U2OS cells were used for 6 ChIP reac-
tions. Disuccinimidyl glutarate (20593, Pierce) was
applied to the washed cells at a final concentration of 2
mM in PBS pH 8.0, supplemented with 1 mM MgCl2for
30 min at RT. The cells were washed, 1.42% formaldehyde
in PBS was applied for 20 min, and the reaction was
stopped with glycine. Subsequently, cells were lysed in 1%
SDS buffer, and the chromatin shearing was performed
using the Bioruptor XL sonicator (Diagenode) at 4°C to
obtain 200–500 bp DNA fragment size. Antibodies were
used for immunoprecipitation of precleared chromatin.
The complexes were collected using either protein G or
protein A sepharose beads (16–201, 16–157, Upstate),
the beads were washed, and the complexes were eluted.
The crosslinking was reversed for 6 hours at 65°C. After
RNase and proteinase K treatment the DNA was purified
using the QIAquick PCR purification kit (Qiagen), and
PCR reactions were performed. The primers used in the
PCR reactions are described in Additional file 2.
Luciferase assay
U2OS cells were transfected in 24-well plates with the
Fugene6 (Roche). After 36 h cells were processed for anal-
ysis with the Dual-Luciferase Reporter Assay System
(Promega). A Renilla reporter (pRL-CMV, pRL-SV40,
Promega) as internal standard was not included, since it
turned out to be variably affected by introduced transcrip-
tion factors. Each transfection experiment was performed
in four parallel wells containing equal numbers of cells.
The mean values, standard deviations and p-values were
calculated. The p-values were obtained using a paired t-
test. In text p-value < 0.01 indicates significant differences,
and highly significant differences are presented as p-value
< 0,001. The total amount of DNA per well was kept con-
stant at 1425 ng by the addition of CMV-GFP. The
reporter-TBP/TBPL1 expression vector ratio was always
10:1. Transfection experiments were repeated three times.
Geminin knock-down
U2OS cells were transfected in 24-well plates with siGE-
NOME SMARTpool human geminin (M-003270-01,
Thermo Fisher Scientific) to obtain a 100 nM final con-
centration, using Dharmafect1 transfection reagent
(Thermo Fisher Scientific). The control cells were treated
in a similar way, except for the siRNA that was replaced by
the siRNA dilution buffer (Roche). After 6 hours the cells
were transfected with reporter and expression plasmids.
After 24 h the cells were processed for analysis with the
Dual-Luciferase Reporter Assay System (Promega).
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